Effective management of gout: an analogy

  • Robert L. Wortmann
    Requests for reprints should be addressed to Robert Wortmann, MD, School of Medicine, East Carolina University, Department of Medicine, Brody 3E-115, Greenville, North Carolina 27858-4354
    Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina, USA
    Search for articles by this author
      The social and economic forces affecting health care today are dictating a new definition of quality medicine. More attention is being given to outcomes and efficiency, as physicians are expected to deliver needed care in a minimum of time. Accordingly, we need to find better ways to educate our patients. The better the education, the better may be patient compliance and outcomes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wallace S.L.
        • Robinson H.
        • Masi A.T.
        • et al.
        Preliminary criteria for the classification of acute arthritis of primary gout.
        Arthritis Rheum. 1977; 30: 895-900
        • Wallace S.L.
        • Bernstein D.
        • Diamond H.
        Diagnostic value of the colchicine therapeutic trial.
        JAMA. 1967; 199: 525-528
        • Rundles R.W.
        • Wyngaarden J.B.
        • Hitchings G.H.
        • et al.
        Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout.
        Trans Asso Am Phys. 1963; 76: 126-140
        • Fam A.G.
        Should patients with interval gout be treated with urate lowering drugs?.
        J Rheumatol. 1995; 21: 151-161
        • Rosenthal A.K.
        • Ryan L.M.
        Treatment of refractory crystal-associated arthritis.
        Rheum Clin North Am. 1995; 21: 151-161
        • Emmerson B.T.
        The management of gout.
        NEJM. 1996; 334: 445-451
        • Schumacher H.R.
        Crystal-induced arthritis.
        Am J Med. 1996; 100: 465-525
        • Kelley W.N.
        • Wortmann R.L.
        Gout and hyperuricemia.
        in: Kelley W.N. Harris Jr, E.D. Ruddy S. Sledge C.B. Textbook of Rheumatology. 5th ed. WB Saunder, Philadelphia1997: 1313-1351